Analysts are counting on record year Carl Zeiss Meditec

Tomorrow the German Carl Zeiss Meditec will report its past quarter's results. Based on the analysts' estimates both the revenue and the net result would be the highest in years. Over the current book year the total revenue will be 1,17 billion euros (consensus estimates). The expected revenue would be a record for the company. This is slightly more than 2016's revenue of 1,09 billion euros.

Historical revenues and results Carl Zeiss Meditec plus estimates 2017

fundamental data

The analysts anticipate for 2017 a record net profit a 124 million euros. For this year the consensus of Carl Zeiss Meditec 's result per share is a profit of 1,43 euros. Based on this the price/earnings-ratio is 35,59.

Per share the analysts expect a dividend of 0,5 cent per share. Carl Zeiss Meditec 's dividend yield thus equals 0,98 percent. The average dividend yield of the pharmaceutical companies is a limited 0,24 percent.

Recent target prices around 47 euros

Deutsche Bank, Berenberg and Nord Landesbank recently provided recommendations for the stock.

Carl Zeiss Meditec 's market value equals around 4,14 billion .

At 9.53 the stock trades 0,12 percent lower at 50,89 euros.

Historical stock prices Carl Zeiss Meditec period 2007-2017

fundamental data carlzeissmeditec News Wire & Equity Research: +31 084-0032-842

Copyright B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.